The epidemiology of non‐alcoholic fatty liver disease

Liver International - Tập 37 Số S1 - Trang 81-84 - 2017
Stefano Bellentani1
1Gastroenterology and Hepatology Service, Clinica Santa Chiara, Locarno, Switzerland

Tóm tắt

AbstractThe increase in Non‐alcoholic Fatty Liver Disease (NAFLD) and the imminent disappearance of chronic viral hepatitis thanks to new and effective therapies is motivating hepatologists to change their clinical approach to chronic liver disease. NAFLD‐cirrhosis or NAFLD‐Hepatocellular Carcinoma (HCC) are now the second cause of liver transplantation in the USA. This short‐review is focused to the epidemiology of NAFLD/Non‐alchoholic Steatohepatitis (NASH), including the definition of this disease which should be revised as well discussing the prevalence, risk factors for progression, natural history and mortality. NAFLD is considered to be the hepatic manifestation of the metabolic syndrome (MS). It affects 25‐30% of the general population and the risk factors are almost identical to those of MS. The natural history involves either the development of cardiovascular diseases or cirrhosis and HCC. HCC can also develop in NASH in the absence of cirrhosis (45% of cases). We conclude that an international consensus conference on the definition, natural history, policies of surveillance and new pharmacological treatments of NAFLD and NASH is urgently needed.

Từ khóa


Tài liệu tham khảo

10.1002/hep.510290347

10.1016/j.jhep.2004.02.013

10.1111/j.1572-0241.2004.04059.x

10.1053/jhep.2000.17894

10.1002/hep.28368

Ludwig J, 1980, Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease, Mayo Clin Proc, 55, 434

10.7326/0003-4819-126-2-199701150-00008

10.1016/j.cgh.2011.03.020

10.1002/hep.21827

10.1016/S0261-5614(99)80015-6

10.1016/j.cgh.2014.04.014

10.1016/S0016-5085(00)70364-7

10.1002/hep.26465

10.2337/dc09-0148

10.1002/hep.20701

10.1136/gut.2009.205088

10.1016/j.jhep.2009.03.019

10.1136/gut.2003.019984

10.1016/j.jhep.2004.09.012

10.7326/0003-4819-132-2-200001180-00004

10.1080/00365520802555991

10.1111/j.1365-2036.2009.04141.x

10.1016/j.numecd.2013.02.007

10.1111/liv.12304

10.1056/NEJMra0912063

10.1136/bmj.d6891

10.1016/j.cgh.2014.04.014

10.1001/jamainternmed.2014.6502

10.1002/hep.26156

10.1002/lt.500030211

10.1002/lt.500030212

10.1097/00007890-199612270-00021

10.1016/j.cgh.2012.10.001

10.1002/hep.22845

10.1007/s10654-007-9181-7

10.1002/hep.23135

10.3748/wjg.v16.i31.3944

10.1002/hep.21827

10.1093/aje/kwq073

10.1038/sj.ejcn.1602588

10.2337/dc07-0349

Radu C, 2008, Prevalence and associated risk factors of non‐alcoholic fatty liver disease in hospitalized patients, J Gastrointestin Liver Dis, 17, 255

10.1097/MEG.0b013e32832fcdf0

10.2337/dc10-2229